Molecular features characterizing non-peptide selectivity to the human B1 and B2 bradykinin receptors
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (1) , 11-14
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Using molecular dynamics for the refinement of atomistic models of GPCRs by homology modelingJournal of Biomolecular Structure and Dynamics, 2017
- Bradykinin in ischemic conditioning-induced tissue protection: Evidences and possible mechanismsEuropean Journal of Pharmacology, 2015
- IcatibantNature Reviews Drug Discovery, 2008
- Effect of different treatments of long‐range interactions and sampling conditions in molecular dynamic simulations of rhodopsin embedded in a dipalmitoyl phosphatidylcholine bilayerJournal of Computational Chemistry, 2007
- Non-peptide ligands for bradykinin receptors 1995 – 2004Expert Opinion on Therapeutic Patents, 2005
- International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological ConsequencesPharmacological Reviews, 2005
- Bradykinin receptor ligands: therapeutic perspectivesNature Reviews Drug Discovery, 2004
- Bradykinin antagonists: discovery and developmentPeptides, 2004
- Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonistsBiochemical Pharmacology, 2003
- Antagonists of B 2 bradykinin receptorsThe FASEB Journal, 1989